NutriBand annual stock-based compensation
2017
2019
2020
2021
2022
2023
2024
2025
2026
NutriBand Stock-Based Compensation Growth & History (NTRB)
NutriBand's stock-based compensation was $2.6M for fiscal 2026.
View full NutriBand company overviewNutriBand annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | $2.6M | $1.2M | +86.95% |
| 2025 | 2025-01-31 | $1.4M | $909,079 | +181.87% |
| 2024 | 2024-01-31 | $499,856 | −$232,274 | −31.73% |
| 2023 | 2023-01-31 | $732,130 | $367,130 | +100.58% |
| 2022 | 2022-01-31 | $365,000 | −$1.6M | −81.79% |
| 2021 | 2021-01-31 | $2.0M | $1.8M | +693.38% |
| 2020 | 2020-01-31 | $252,700 | −$1.5M | −85.67% |
| 2019 | 2019-01-31 | $1.8M | — | — |
| 2017 | 2017-01-31 | $7,770 | — | — |
NutriBand quarterly stock-based compensation
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.21
Q1.22
Q2.22
Q3.22
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
Q2.27
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2027 | 2026-07-31 | $220,370 | $179,320 | +436.83% |
| Q1 2027 | 2026-04-30 | $552,458 | $489,108 | +772.07% |
| Q4 2026 | 2026-01-31 | $98,513 | −$757,087 | −88.49% |
| Q3 2026 | 2025-10-31 | $2.5M | $2.5M | — |
| Q2 2026 | 2025-07-31 | $41,050 | −$89,330 | −68.52% |
| Q1 2026 | 2025-04-30 | $63,350 | −$359,605 | −85.02% |
| Q4 2025 | 2025-01-31 | $855,600 | $855,600 | — |
| Q3 2025 | 2024-10-31 | $0 | −$424,826 | — |
| Q2 2025 | 2024-07-31 | $130,380 | $130,380 | — |
| Q1 2025 | 2024-04-30 | $422,955 | $347,925 | +463.71% |
| Q4 2024 | 2024-01-31 | $0 | — | — |
| Q3 2024 | 2023-10-31 | $424,826 | — | — |
| Q2 2024 | 2023-07-31 | $0 | — | — |
| Q1 2024 | 2023-04-30 | $75,030 | — | — |
| Q3 2022 | 2021-10-31 | $529,400 | $517,400 | +4311.67% |
| Q2 2022 | 2021-07-31 | $97,500 | — | — |
| Q1 2022 | 2021-04-30 | $127,500 | — | — |
| Q3 2021 | 2020-10-31 | $12,000 | $12,000 | — |
| Q4 2020 | 2020-01-31 | $0 | $0 | — |
| Q3 2020 | 2019-10-31 | $0 | $0 | — |
| Q2 2020 | 2019-07-31 | $0 | −$1.5M | — |
| Q1 2020 | 2019-04-30 | $252,700 | −$24,800 | −8.94% |
| Q4 2019 | 2019-01-31 | $0 | — | — |
| Q3 2019 | 2018-10-31 | $0 | −$20,000 | — |
| Q2 2019 | 2018-07-31 | $1.5M | — | — |
| Q1 2019 | 2018-04-30 | $277,500 | — | — |
| Q3 2018 | 2017-10-31 | $20,000 | — | — |
NutriBand stock-based compensation trends
Over the last five fiscal years, NutriBand's stock-based compensation increased from $2.0M to $2.6M, a change of $629,121. The latest reported quarter, Q2 2027, shows $220,370.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NutriBand source filings ↗